Takaaki Tokito
Kurume University(JP)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer(2017)4,429 cited
- → Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC(2018)2,751 cited
- → Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy(2016)187 cited
- → Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer(2014)178 cited
- → Significance of Programmed Cell Death-Ligand 1 Expression and its Association with Survival in Patients with Small Cell Lung Cancer(2014)175 cited
- → A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis(2020)97 cited
- → Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients(2016)93 cited
- → Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples(2015)77 cited
- → Phase II study of tepotinib in NSCLC patients with METex14 mutations.(2019)60 cited
- → The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review(2018)56 cited